FDA PMA
FDA Class 3
Approved
🇺🇸 United States
Tricuspid Valve Repair Device, Percutaneously Delivered
PMA: P230007
·
Supplement: S002
·
Decision Jun 20, 2024
Classifications
1
FEI Numbers
3
Registration Numbers
3
Basic Information
- Device Name
- Tricuspid Valve Repair Device, Percutaneously Delivered
- Trade Name
- TriClip G4 Delivery System
- PMA Number
- P230007
- Supplement Number
- S002
- Device Class
- FDA Class 3
- Product Code
- NPS
- Generic Name
- Tricuspid valve repair device, percutaneously delivered
- Medical Specialty
- Unknown
- Advisory Committee
- Cardiovascular
- Decision
- Approved
- Decision Code
- APPR
- Decision Date
- June 20, 2024
- Date Received
- April 22, 2024
- Supplement Type
- Real-Time Process
- Supplement Reason
- Labeling Change - Indications/instructions/shelf life/tradename
- Expedited Review
- N
Advisory Committee Statement
alternate model numbers under the existing trade name for the MitraClip G4 System, and alternate trade name and model numbers for the TriClip G4 System
Classifications
This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.
| Product Code | Device Name | Device Class | Medical Specialty |
|---|---|---|---|
| NPS | Tricuspid Valve Repair Device, Percutaneously Delivered | FDA class 3 | Unknown |